BioInvent International is a Swedish research, pharmaceutical and life science company with a focus on clinical development and development of, among other things, antibody drugs for immunotherapy against cancer. The company was founded in 1983 by, among others, Professor Carl Borrebaeck and has been listed on the Stockholm Stock Exchange since 2001.
Wikipedia